Daily Equity Report 05 AUGUST 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 05 THAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 10980.00 INDIAN EQUITY BENCHMARK - registered a strong recovery from the intraday lows and ended on a positive note on August 2 with Nifty finished a Benchmark indices NIFTY 37018.32 tad below 11,000 mark. At close the Sensex was up 118.69 CLOSE PREVIOUS points at 37,137.01, while Nifty was up 17.40 points at NIKKEI 21540.99 10,997.40. About 1104 shares have advanced, 1339 shares declined, and 132 shares are unchanged. Indiabulls Housing, 27565.70 Tata Steel, SBI, Coal India and Wipro were among major 1998.13 losers on the Nifty, while gainers include Bharti Airtel, Asian SECTORIAL INDICES Paints, Eicher Motors, Bajaj Auto and Maruti Suzuki. Auto, CLOSE infra, IT witnessed some buying, while PSU banks, metal and CNX 100 energy ended on negative note. Midcap index ended flat, S&P CNX 500 while smallcap index was down 0.5 percent. GLOBAL FACE -0.18 CNX 200 ! BANK NIFTY 28204.95 -0.57 Asian Market - Asian markets finished sharply lower today with shares in Hong Kong leading the region. The Hang Seng is down 2.35% while Japan's Nikkei 225 is off 2.11% and TOP GAINERS China's Shanghai Composite is lower by 1.41%. CLOSE CHANGE (%) BHARTIARTL 346.55 ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The Bovespa gained 0.31%, while the IPC led the S&P 500 lower. They fell ASIANPAINT 1.26% and 0.90% respectively. BAJAJ-AUTO ! TOP LOSERS European markets – European markets are sharply lower today with shares in France off the most. The CAC 40 is down CLOSE 2.75% while Germany's DAX is off 2.55% and London's FTSE 100 is lower by 1.78%. 477.00 407.45 -2.99 SBIN 307.95 -2.90 COALINDIA 196.90 -2.74 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY SELL ON RISE SCRIPT CLOSE (%) 6.99 BHARTIARTL PIVOT POINTS P 10975 S3 10513 S2 10744 S1 R1 11102 R2 11206 RESISTANCE R1-11120 R2-11250 R3 11437 2.47 MARUTI 10870 2.35 SUPPORT S1-10700 S2-10850 TECHM 636.80 1.78 MARKET MOVERS DOWNSIDE CLOSE (%) IBULHSGFIN WIPRO VEDL ONGC NET BUY (CR.) NET INSTITUTION SELL (CR) FII 6217.84 TREND STRATEGY SELL ON RISE 4029.91 PIVOT POINTS P 28361 SUPPORT NSE TOTALS S2 27727 S1 28038 R2 R3 29629 DECLINE S 27093 28672 28995 RESISTANCE R1-28580 R2-28790 INDICES BANK NIFTY NIFTY 4 8 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! ! Exide Industries net profit at Rs224cr in Q1 Exide Industries Limited, on Q1FY20 net profit has risen by 7% to Rs224.29cr from Rs209.92cr for the corresponding quarter ended June 30, 2018. However, revenue stood flat in Q1 at Rs2, 779.25cr as against Rs2, 772.46cr for the corresponding quarter ended June 30, 2018. EBITDA came up by 4% at Rs407.7cr in Q1. G Chatterjee, MD & Automotive Batteries remains under growth in UPS, Telecom, as well as other Infrastructure segments, continued during the first quarter. Marico rises 3% on healthy Q1 numbers Marico is trading up 1.5% after posting health Q1 earnings yesterday. Revenue from operations grew 7% Rs2,166cr with an underlying domestic volume growth of 6% and constant currency international business.There was inventory correction in the Gulf business. Adjusting for the same, constant currency growth business stood at 9%.Easing raw material costs in the domestic and key overseas markets led to gross margin expansion of 524bps expanded 324 bps, as the Company stepped up A&P spends by 32% to support its core and new franchises. Zydus Saroglitazar Diabetes Phase-III Zydus Cadila announced that it has completed Phase 3 Clinical Trial in India of Saroglitazar Mg for treating Type 2 Diabetes. The trial was a multi-centric, randomized, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with Type 2 Diabetes Mellitus. The Phase 3 trial enrolled 1140 subjects and studied the patients over a period of outcome of the trial was a change from baseline glycosylated haemoglobin (HbAlc) for Saroglitazar 4 mg, 2 mg and Pioglitazone 30 mg at 24 weeks. The study also measured glycosylated haemoglobin (HbAlc) and other secondary outcome measures including fasting plasma glucose, Triglyceride Lipoprotein cholesterol, Lipoprotein (VLDL) cholesterol, Lipoprotein (HDL) cholesterol, Total Cholesterol (TC) cholesterol, Non HDL cholesterol, Apolipoprotein (Apo) Al, Apo B between completes Phase-III trials Type-2 completes Magnesium MellitusZydus Friday, reported that its CEO said that demand of pressure while 56 weeks. The primary ! in yoy to growth of 7% one-time in the trade cholesterol, Low Density Very Low Density High Density a in the International 4 mg, 2 mg and on a yoy basis. EBITDA ! HDFC spurts 2.5% after Q1 net profit jumps 46% Shares of Housing Development Finance Corporation (HDFC) soared 2.5% in the afternoon session after the company has reported 46% jump in its Q1FY20 net profit at Rs3, 203cr as against Rs2, 190cr in the same quarter last year. Revenue was up 30.6% at Rs12, 990cr in Q1FY20 as against Rs9, 947.35cr for the corresponding quarter ended June 30, 2018. NII in Q1 stood at Rs2, 739cr, as per the filing. The company's loan book grew 11.2% at Rs4.16 lakh cr. Gross NPAs were up marginally at 1.29% against 1.22% on a qoq basis. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : TRENT DATE : 05/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY TRENT IN CASH ABOVE 444 TGT 452 SL 436 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.